ChronicHepatitisC相关论文
目的:慢性丙型肝炎抗病毒治疗有助于代谢状态的改善，但接受直接抗病毒药物（DAA）治疗后血清尿酸（SUA）水平的变化尚不明确。本研究旨在观......
9岁患儿因反复肝脏生物化学指标异常于2018年5月就诊。诊断为慢性丙型肝炎，GT3a型。给予护肝药物治疗1年余，肝脏生物化学指标始终不......
...
Effect of soy protein supplementation in patients with chronic hepatitis C: A randomized clinical tr
...
...
Accuracy of M2BPGi(R),compared with fibroscan,in analysis of liver fibrosis in patients with hepatit
...
Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Re
Background/Aims: No clinical model exists to predict the occurrence of hepatocellular carcinoma in sustained virologic r......
Clinical model for predicting the post-sustained virologic responses of hepatocellular carcinomas in
Background/Aims: A clinical model for predicting the occurrence of post-sustained virologic responses of hepatocellular ......
Mutational diversity of NSSA and NS3 during triple therapy (telaprevir, pegylated-interferon-alpha 2
Background and aim: Telaprevir, a nonstructural (NS)3/4A protease inhibitor, is a direct-acting antiviral drug that inhi......
Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin
BACKGROUND: Treatment of chronic hepatitis C (CHC) with pegylated interferon-alpha/ribavirin is associated with wellchar......
...
...
Extrahepatic manifestations of chronic hepatitis C virus infection:297 cases from a tertiary medical
...
目的了解索磷布韦/维帕他韦（SOF/VEL）治疗慢性丙型肝炎（CHC）患者的临床疗效及安全性。方法收集广州医科大学附属市八医院2019年1月至20......
病毒性肝炎是由多种肝炎病毒引起的一组全身性传染病。其中乙型、丙型多呈慢性感染,少数病例可发展为肝硬化或肝细胞癌。辅助性T细......
2013年10月24日讯 杨森有限责任公司研究与开发部今天宣布美国食品药品监督管理局（FDA）抗病毒药顾问委员会根据临床试验结果，一致投票......
目的：探讨了慢性丙型肝炎患者血清脯氨酸肽酶活性与IGF-I、SS水平检测的临床意义。方法：应用生化法和化学发光法对30例慢性丙型肝炎......
AIM: To investigate the prevalence and the risk factors of glucose intolerance in Chinese patients with chronic hepatiti......
AIM: To study hepatic virus C (HCV) RNA and HCV proteinexpression in peripheral blood mononuclear cells (PBMCs)of patien......
Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C pat
AIM: To estimate the amount of apoptosis among healthy HBsAg carriers, patients with chronic HBV infection treated with ......
Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patien
AIM: Smoking may affect adversely the response rate to interferon-α. Our objective was to verify this issue among chron......
Natural history of chronic hepatitis C in patients on hemodialysis:Case control study with 4-23 year
AIM: Hepatitis C virus (HCV) infection is very common among end-stage kidney disease patients on hemodialysis, but its n......
AIM: To clarify the effect of SEN virus (SENV) infection on a combination therapy including interferon alfa (IFN-α) or ......
Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high
AIM: The clinical significance of co-infection of SENV-D among patients with chronic hepatitis C (CHC) and response of b......
Herbal medicine Ninjinyoeito ameliorates ribavirin-induced anemia in chronic hepatitis C: A randomiz
AIM: Ribavirin (RBV) shows a strong antiviral effect on hepatitis C virus when used in combination with interferon.Howev......
Expression of interferon-alpha/beta receptor protein in liver of patients with hepatitis C virus-rel
AIM: To study the expression of interferon-alpha/beta (IFN-α/β) receptor protein in liver of patients with hepatitis C......
Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C a
AIM: To assess the prevalence of the two mutations, C282Y and H63D of HFE gene, in healthy subjects, patients with chron......
Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical live
AIM: To determine serum leptin levels and investigate their correlations with anthropometric and metabolic parameters an......
Expression of bcl-2 protein in chronic hepatitis C: Effect of interferon alpha 2b with ribavirin the
AIM: Mechanisms responsible for persistence of HCV infection and liver damage in chronic hepatitis C are not clear. Apop......
目的 探讨聚乙二醇干扰素(IFN)α-2a联合病毒唑治疗自身免疫抗体阳性慢性丙型肝炎的临床疗效.方法 慢性丙型肝炎患者93例,筛查自身......
...
Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis
AIM: To evaluate the response to pegylated-interferon alpha 2a in chronic hepatitis C patients on chronic haemodialysis.......
AIM: Although increased insulin-like growth factor-I receptor (IGF-IR) gene expression has been reported in hepatocellul......
Risk factors for retinopathy associated with interferon α-2b and ribavirin combination therapy in pa
AIM: To elucidate the frequency and risk factors for retinopathy in patients with chronic hepatitis C who are treated by......
Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients w
AIM: To identify the anthropometric, metabolic and mood state in hepatitis C virus (HCV)-infected patients from the west......
Four-week pegylated interferon α-2a monotherapy for chronic hepatitis C with genotype 2 and low vira
AIM: To assess the efficacy and advantages of 4-wk pegylated interferon α-2a (peg-IFN-α2a) monotherapy for chronic hep......
In order to increase the positive detection rate of HCV RNA in the patients with chronic hepatitis C (CHC), RT-PCR was u......
Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response
AIM:To investigate relapse predictors in chronic hepatitis C (CHC) patients with end-of-treatment response (ETR), after ......
We have read with interest the paper published in issue 2, volume 16 of World Joal of Gastroenterology 2010 by Nakamura ......
We report a case of severe thrombocytopenia following pegylated interferon-α 2a (Peg-IFN-α 2a) treatment of hepatitis ......
目的 比较慢性丙型肝炎患者接受聚乙二醇干扰素α( Peg IFNα) -2a或Peg IFNα-2b联合利巴韦林治疗后的疗效差异.方法 对46例慢性......
